Capital Analysts LLC’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4K Hold
44
﹤0.01% 1404
2025
Q4
$4K Hold
44
﹤0.01% 1375
2025
Q3
$4K Buy
44
+1
+2% +$99 ﹤0.01% 1343
2025
Q2
$4K Hold
43
﹤0.01% 1284
2025
Q1
$5K Hold
43
﹤0.01% 1236
2024
Q4
$5K Hold
43
﹤0.01% 1161
2024
Q3
$5K Hold
43
﹤0.01% 1140
2024
Q2
$5K Hold
43
﹤0.01% 1050
2024
Q1
$6K Hold
43
﹤0.01% 975
2023
Q4
$5K Hold
43
﹤0.01% 969
2023
Q3
$5K Hold
43
﹤0.01% 984
2023
Q2
$6K Hold
43
﹤0.01% 880
2023
Q1
$6K Hold
43
﹤0.01% 856
2022
Q4
$5K Buy
43
+1
+2% +$116 ﹤0.01% 921
2022
Q3
$4K Hold
42
﹤0.01% 931
2022
Q2
$4K Hold
42
﹤0.01% 902
2022
Q1
$5K Sell
42
-1
-2% -$121 ﹤0.01% 830
2021
Q4
$5K Sell
43
-94
-69% -$12.3K ﹤0.01% 893
2021
Q3
$19K Buy
137
+94
+219% +$13.8K ﹤0.01% 710
2021
Q2
$7K Sell
43
-94
-69% -$15.2K ﹤0.01% 793
2021
Q1
$22K Buy
+137
New +$21.2K ﹤0.01% 707
2015
Q2
Sell
-379
Closed -$43.2K 400
2015
Q1
$43.2K Hold
379
0.01% 294
2014
Q4
$41.7K Hold
379
0.01% 275
2014
Q3
$37K Sell
379
-54
-12% -$5.31K 0.01% 262
2014
Q2
$43.6K Hold
433
0.01% 244
2014
Q1
$39.7K Hold
433
0.01% 241
2013
Q4
$39.1K Buy
433
+42
+11% +$3.63K 0.01% 231
2013
Q3
$31.2K Buy
+391
New +$30.8K 0.01% 231

Other funds holding ZBH

Capital Analysts LLC's ZBH Position: Q1 2026 in Review

Capital Analysts LLC held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 44 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1404.

Capital Analysts LLC first reported a position in ZBH in Q3 2013 and has held it in 28 quarters since. The position peaked at $43.6K in Q2 2014. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Capital Analysts LLC held 44 shares of Zimmer Biomet worth $4K as of Q1 2026.
  • Capital Analysts LLC left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up ﹤0.01% of Capital Analysts LLC's portfolio in Q1 2026, its #1404 holding.
  • Capital Analysts LLC first reported a position in Zimmer Biomet in Q3 2013 and has held it in 28 quarters since.
  • Capital Analysts LLC's Zimmer Biomet position peaked at $43.6K in Q2 2014.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.